Amastigote susceptibility results of the <i>in vivo</i> resistance selection procedure to PMM-MIL combination therapy.
收藏NIAID Data Ecosystem2026-03-10 收录
数据链接：
官方服务：
资源简介：
No difference was observed between IC50 of the wild-type (ITMAP263 WT) and the strain that was exposed five times to high concentrations of PMM and MIL (ITMAP263 PMM/MIL). Exposure to PMM alone (ITMAP263 PMM) revealed a significant susceptibility decrease (indicated in bold)[14]. (ND: not done).
创建时间：
2017-05-25
